Demannose

Demannose

SCHEMBL6315218

C=CC(=O)OCCCCCCCC/C=C\CCCCCCCC.O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
HPGD P15428 1/20 0.47
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 1/20 0.43
DGKA P23743 1/20 0.42
FAAH O00519 3/20 0.40
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCD Q05655 1/20 0.38
PRKCA P17252 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mannitol SCHEMBL28918397 0.87 TSHR (0.62) TSHRHPGDALDH1A1CYP3A4
Demannose SCHEMBL28051236 0.83 TSHR (0.45) TSHRHPGDALDH1A1CYP3A4
SCHEMBL126607 0.81 TSHR (0.70) TSHRHPGDALDH1A1CYP3A4FAAH
SCHEMBL15542854 0.81 TSHR (0.70) TSHRHPGDALDH1A1CYP3A4FAAH
SCHEMBL30162492 0.81 TSHR (0.70) TSHRHPGDALDH1A1CYP3A4FAAH
SCHEMBL15978514 0.81 TSHR (0.70) TSHRHPGDALDH1A1CYP3A4FAAH
SCHEMBL15542858 0.81 TSHR (0.70) TSHRHPGDALDH1A1CYP3A4FAAH
SCHEMBL126605 0.81 TSHR (0.70) TSHRHPGDALDH1A1CYP3A4FAAH
SCHEMBL16180095 0.80 TSHR (0.72) TSHRHPGDALDH1A1CYP3A4FAAH
SCHEMBL16180094 0.80 TSHR (0.72) TSHRHPGDALDH1A1CYP3A4FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884842-B2 Molecular compounds having complementary surfaces to targets ALNIS BIOSCIENCES, INC. (US) 2005-04-26 US disclosed
US-20030153001-A1 Molecular compounds having complementary surfaces to targets ALNIS, LLC 2003-08-14 US disclosed
EP-1025066-A2 MOLECULAR COMPOUNDS HAVING COMPLEMENTARY SURFACES TO TARGETS Alnis, LLC (US) 2000-08-09 EP disclosed
WO-1999019276-A2 MOLECULAR COMPOUNDS HAVING COMPLEMENTARY SURFACES TO TARGETS ALNIS, LLC (US) 1999-04-22 WO disclosed